Karmanos Cancer Institute/BMT — Detroit, Michigan

Karmanos Cancer Institute/BMT is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute/BMT has participated in 7 clinical trials.

Therapeutic areas: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma.

Sponsors: Medical College of Wisconsin, National Heart, Lung, and Blood Institute (NHLBI).

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute/BMT?

Karmanos Cancer Institute/BMT has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute/BMT conducted?

Karmanos Cancer Institute/BMT has 7 clinical trials on record. Their work covers Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma.

Is Karmanos Cancer Institute/BMT accredited by Crixeo Health?

Karmanos Cancer Institute/BMT has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Institute/BMT?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.